INTEGB (INTEGB) News
Follow INTEGB (INTEGB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Integrum implants first U.S. patient with e-OPRA under FDA IDE
Integrum said its e-OPRA system was implanted in the first U.S. patient under an FDA IDE at Northwestern Memorial Hospital. A NIH-funded study plans 8 patients and is expected to conclude in 2030.
EQUITY | Sep 17, 2026, 02:00 PM UTC
M
Integrum raises about SEK 22.9M via directed share issue
Integrum completed a directed issue of 2,666,791 Class B shares at SEK 8.6, raising approximately SEK 22.9M before costs; dilution is about 9.1%. Proceeds will support OPRA commercialization and other initiatives.
EQUITY | Sep 16, 2026, 05:25 PM UTC
L
Integrum publishes Annual Report 2025/26
Integrum AB (publ) has published its Annual Report for the financial year 1 May 2025 to 30 April 2026.The Annual Report is available on the company’s website: PDF version of the Annual Report is also attached to this pre
NEWS | Sep 12, 2026, 08:40 PM UTC
M
Integrum: Ukraine to launch state-funded osseointegration pilot
Integrum says Ukraine plans a state-funded osseointegration pilot program.
GEOPOLITICS | Sep 08, 2026, 02:05 PM UTC
M
Integrum AB says Ukraine Cabinet backs state-funded osseointegration pilot
Integrum AB was informed the Cabinet of Ministers of Ukraine decided to introduce a state-funded pilot program for bone-anchored prostheses. The company says its OPRA® Implant System has already been used in…
GEOPOLITICS | Sep 08, 2026, 02:00 PM UTC
L
Integrum Q1 sales rise on higher S1 surgeries
Integrum reports higher Q1 sales, citing increased S1 surgeries as a key driver, according to the company press release.
EARNINGS | Sep 03, 2026, 05:25 AM UTC
L
Integrum B net sales rise 27% YoY to SEK 30.2 million
Integrum AB Class B reports net sales up 27% year-over-year to SEK 30.2 million. S1 surgeries increased 17% and the company achieved positive EBITDA, citing digital and bionics investment plus cost reductions.
EARNINGS | Sep 03, 2026, 05:16 AM UTC
L
Integrum invites to presentation of Q1 2026/27 results
Integrum has invited investors to a presentation covering its Q1 2026/27 results.
EQUITY | Aug 31, 2026, 05:00 PM UTC